ADMA Biologics, Inc.
ADMA
$20.11
$0.391.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.20% | 2.31% | 58.03% | 100.86% | 16.92% |
| Total Receivables | 174.58% | 264.38% | 100.34% | 82.34% | 60.10% |
| Inventory | 14.47% | 6.48% | -3.12% | -1.54% | 5.32% |
| Prepaid Expenses | -27.40% | 46.42% | 129.59% | 50.52% | 86.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.54% | 31.57% | 27.28% | 28.95% | 16.26% |
|
|
|||||
| Total Current Assets | 26.54% | 31.57% | 27.28% | 28.95% | 16.26% |
| Net Property, Plant & Equipment | 25.86% | 4.70% | 1.57% | -0.20% | -3.06% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| Total Other Intangibles | 1.24% | 10.02% | 40.81% | -7.82% | 1.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,330.33% | 1,591.21% | 1,411.51% | 1,825.85% | -13.44% |
| Total Assets | 45.59% | 48.35% | 45.51% | 48.45% | 11.93% |
|
|
|||||
| Total Accounts Payable | 49.94% | 109.95% | 19.91% | 29.11% | 47.63% |
| Total Accrued Expenses | -3.07% | 4.92% | -26.82% | -6.30% | -11.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 205.28% | -1.31% | 8.69% | 16.56% | 21.38% |
| Total Finance Division Other Current Liabilities | 54.71% | 225.03% | 151.21% | 115.04% | 25.46% |
| Total Other Current Liabilities | 54.71% | 225.03% | 151.21% | 115.04% | 25.46% |
| Total Current Liabilities | 25.84% | 69.64% | 0.77% | 11.52% | 7.29% |
|
|
|||||
| Total Current Liabilities | 25.84% | 69.64% | 0.77% | 11.52% | 7.29% |
| Long-Term Debt | -30.83% | -44.00% | -44.57% | -44.61% | -28.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.00% | 1.30% | -12.53% | -12.46% | -11.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -58.04% | -34.65% | -24.55% | -15.20% | -2.19% |
| Total Liabilities | -13.37% | -14.92% | -30.44% | -28.00% | -19.66% |
|
|
|||||
| Common Stock & APIC | 2.00% | 2.52% | 2.02% | 2.52% | 1.92% |
| Retained Earnings | 49.81% | 45.78% | 42.33% | 39.05% | 13.94% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 85.94% | 111.57% | 142.94% | 158.14% | 53.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 85.94% | 111.57% | 142.94% | 158.14% | 53.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 85.94% | 111.57% | 142.94% | 158.14% | 53.13% |
|
|
|||||